“三叉神经痛可停”治疗原发性三叉神经痛的临床研究

Clinical research of Sanchashenjing Tongketing on treatment of primary trigeminal neuralgia

目的:观察“三叉神经痛可停”治疗原发性三叉神经痛的疗效。方法:采用随机双盲法进行研究,将40例患者随机分为治疗组和对照组各20例,治疗组予以“三叉神经痛可停”口服,对照组予以苯妥英钠口服,疗程21d。结果:治疗组总有效率90．0％,对照组总有效率50．0％,差异有显著性意义(P<0．025)。结论:“三叉神经痛可停”对原发性三叉神经痛有较好疗效。

Objective: To investigate the curative effect of Shanchashenjing Tongketing on primary trigeminal neuralgia. Methods: 40 patients were divided randomly into therapeutic group and control group, Sanchashenjing Tongketing was taked orally in therapeutic group and difetoin orally in control group for 21 days. Results: The total effective rate was 90.0% in the therapeutic group and 50.0% in the control group, which showed that the difference was significant (P<0.025). Conclusion: the Sanchashenjing Tongketing has a good effect for primary trigeminal neuralgia.